This image is just a reminder that we are not the only ones keeping a close eye on Silo Pharma, Inc. (Nasdaq: SILO). (7)
🔑 Key Developments:
📊 Breakthrough Results: Silo’s study revealed a new drug formulation that significantly improves mood stability in depression
patients, without the common side effects of current treatments.(2)
💼 Strong Pipeline: Silo is advancing its SPC-15 program for PTSD to the clinic and preparing to submit a pre-IND application to the FDA.(2)
💡 Positive Forecast: The stock holds positive signals from both short and long-term moving averages, indicating strong future performance.(4)
📊 Analyst Target: One analyst has a positive outlook with a price target of
$10.00, reflecting a potential 392% upside from yesterday’s close. (1)(4)(5)
🏍️ Solid Performance: With a YTD return of +40.97%, Silo is already showing strong momentum. (1)(5)
With a winning combination of groundbreaking achievements, solid
financials, and strong leadership, Silo Pharma, Inc. (Nasdaq: SILO) is one company you will definitely want to keep a close eye on. 👀 👀
Keep watching as Power Week continues to deliver explosive updates and incredible opportunities. Think of this as an early 4th of July celebration with more fireworks to come!
To your success,
Max Masters
Co-founder,
Market Tips Newsletter
Sources:
1. https://finance.yahoo.com/quote/SILO/
2. https://finance.yahoo.com/news/silo-pharma-announces-positive-results-124500174.html
3. https://stockinvest.us/stock/SILO
4. https://stockanalysis.com/stocks/silo/
5. https://finance.yahoo.com/quote/SILO/history/
6. https://finance.yahoo.com/news/silo-pharma-submits-pre-investigational-124100723.html
7. https://www.tipranks.com/stocks/silo/technical-analysis
